News Tagrisso trial halted early after ‘overwhelming’ efficacy A phase III trial for AstraZeneca’s lung cancer drug Tagrisso (osimertinib) will be unblinded early after strong results.
News Pharma given COVID-19 test 'call to arms' by health secretar... UK health secretary Matt Hancock has asked pharma and biotech firms to help the country find antibody tests that work against COVID-19 in a bid to find an exit strategy from the lockdown th
News Hengrui gets world-first okay for platelet drug hetrombopag Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
